These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 30059164)

  • 21. Detection of transcriptionally active high-risk human papillomavirus in patients with oesophageal carcinoma by real-time PCR.
    Kotian S; Ramesh PS; Shetty J; Laxminarayana KPH; Shetty V; Devegowda D
    J Cancer Res Ther; 2024 Jul; 20(5):1440-1445. PubMed ID: 39412909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
    Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer.
    Schlecht NF; Brandwein-Gensler M; Nuovo GJ; Li M; Dunne A; Kawachi N; Smith RV; Burk RD; Prystowsky MB
    Mod Pathol; 2011 Oct; 24(10):1295-305. PubMed ID: 21572401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RPRD1B is a potentially molecular target for diagnosis and prevention of human papillomavirus E6/E7 infection-induced cervical cancer: A case-control study.
    Wen N; Bian L; Gon J; Meng Y
    Asia Pac J Clin Oncol; 2021 Jun; 17(3):230-237. PubMed ID: 32866332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.
    Jordan RC; Lingen MW; Perez-Ordonez B; He X; Pickard R; Koluder M; Jiang B; Wakely P; Xiao W; Gillison ML
    Am J Surg Pathol; 2012 Jul; 36(7):945-54. PubMed ID: 22743284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC.
    Linge A; Schötz U; Löck S; Lohaus F; von Neubeck C; Gudziol V; Nowak A; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Bunea H; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Lauber K; Pigorsch S; Combs SE; Mönnich D; Zips D; Baretton GB; Buchholz F; Krause M; Belka C; Baumann M;
    Radiother Oncol; 2018 Apr; 127(1):27-35. PubMed ID: 29295747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
    Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
    Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility study of a human papillomavirus E6 and E7 oncoprotein test for the diagnosis of cervical precancer and cancer.
    Zhang JJ; Cao XC; Zheng XY; Wang HY; Li YW
    J Int Med Res; 2018 Mar; 46(3):1033-1042. PubMed ID: 29322839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
    Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
    J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic and diagnostic validity of p16/Ki-67, HPV E6/E7 mRNA, and HPV DNA in women with ASCUS: a follow-up study.
    Ren C; Zhu Y; Yang L; Zhang X; Liu L; Wang Z; Jiang D
    Virol J; 2019 Nov; 16(1):143. PubMed ID: 31752941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus 16/18 E7 viral loads predict distant metastasis in oral cavity squamous cell carcinoma.
    Huang CG; Lee LA; Tsao KC; Liao CT; Yang LY; Kang CJ; Chang KP; Huang SF; Chen IH; Yang SL; Lee LY; Hsueh C; Chen TC; Lin CY; Fan KH; Chang TC; Wang HM; Ng SH; Yen TC
    J Clin Virol; 2014 Oct; 61(2):230-6. PubMed ID: 25097016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double demonstration of oncogenic high risk human papilloma virus DNA and HPV-E7 protein in oral cancers.
    Pannone G; Santoro A; Carinci F; Bufo P; Papagerakis SM; Rubini C; Campisi G; Giovannelli L; Contaldo M; Serpico R; Mazzotta M; Lo Muzio L
    Int J Immunopathol Pharmacol; 2011; 24(2 Suppl):95-101. PubMed ID: 21781453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of high-risk human papillomavirus infection in oral and oropharyngeal squamous cell carcinoma in non-smoking and non-drinking patients: a clinicopathological and molecular study of 46 cases.
    Laco J; Vosmikova H; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Nekvindova J; Vosmik M; Cermakova E; Ryska A
    Virchows Arch; 2011 Feb; 458(2):179-87. PubMed ID: 21221634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between human papillomavirus and oral cancer: a literature review.
    Shigeishi H
    Int J Clin Oncol; 2023 Aug; 28(8):982-989. PubMed ID: 36929094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of E6/E7 mRNA from 'high risk' human papillomavirus in relation to CIN grade, viral load and p16INK4a.
    Andersson S; Hansson B; Norman I; Gaberi V; Mints M; Hjerpe A; Karlsen F; Johansson B
    Int J Oncol; 2006 Sep; 29(3):705-11. PubMed ID: 16865288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of human papilloma virus in oral tongue squamous cell carcinoma.
    Elango KJ; Suresh A; Erode EM; Subhadradevi L; Ravindran HK; Iyer SK; Iyer SK; Kuriakose MA
    Asian Pac J Cancer Prev; 2011; 12(4):889-96. PubMed ID: 21790221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of high-risk HPV 16 and 18 in Chinese patients with oral squamous cell carcinoma and oral potentially malignant disorders.
    Chen XJ; Sun K; Jiang WW
    Virol J; 2016 May; 13():81. PubMed ID: 27206495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uniplex E6/E7 PCR method detecting E6 or E7 genes in 39 human papillomavirus types.
    Okodo M; Okayama K; Teruya K; Sasagawa T
    J Med Virol; 2018 May; 90(5):981-988. PubMed ID: 29314149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical Evaluation of E6/E7 HPV Oncoproteins Staining in Cervical Cancer.
    Stiasny A; Kuhn C; Mayr D; Alexiou C; Janko C; Wiest I; Jeschke U; Kost B
    Anticancer Res; 2016 Jun; 36(6):3195-8. PubMed ID: 27272848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seropositivity of HPV 16 E6 and E7 and the risk of oral cancer.
    Wong GR; Ha KO; Himratul-Aznita WH; Yang YH; Wan Mustafa WM; Yuen KM; Abraham MT; Tay KK; Karen-Ng LP; Cheong SC; Zain RB
    Oral Dis; 2014 Nov; 20(8):762-7. PubMed ID: 24320099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.